At a glance
- Originator Boehringer Ingelheim
- Class Cardiotonics
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 14 Oct 1994 Discontinued-preregistration for Heart failure (Unknown route)